95 related articles for article (PubMed ID: 36967521)
1. Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells.
Xing X; Wang X; Liu M; Guo Q; Wang H
Cancer Biol Ther; 2023 Dec; 24(1):2193114. PubMed ID: 36967521
[TBL] [Abstract][Full Text] [Related]
2. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.
Zhao J; Li Z; Zhang H; Qin T; Zhao J; Pei Q
Chem Biol Drug Des; 2024 May; 103(5):e14533. PubMed ID: 38684373
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-155.
Zheng X; Rui H; Liu Y; Dong J
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020073. PubMed ID: 33194147
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
6. Primary small-cell carcinoma in the lung was found after the cold snare polypectomy of the small metastatic lesion in the cecum: A case report.
Suto D; Yoshida M; Yamada H; Akita T; Osawa Y; Sato K; Otake T; Nakazato Y; Arakawa N; Ohdaira H; Suzuki Y; Kohgo Y
DEN Open; 2024 Apr; 4(1):e266. PubMed ID: 37383627
[TBL] [Abstract][Full Text] [Related]
7. Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer.
Wang Y; Meng L; Meng S; Huang L; Luo S; Wu X; Gong X
Cancer Biol Ther; 2023 Dec; 24(1):2203332. PubMed ID: 37131290
[TBL] [Abstract][Full Text] [Related]
8. Melanoma stem cell vaccine induces effective tumor immunity against melanoma.
Yin Q; Zhao N; Chang Y; Dong M; Xu M; Xu W; Jin HF; Liu W; Xu N
Hum Vaccin Immunother; 2023 Dec; 19(1):2158670. PubMed ID: 37067182
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1
Liu S; Huang C; Huang C; Huang Y; Yu Y; Wu G; Guo F; Jiang Y; Wan S; Zhu Z; Tian Y; Zhu J; Zhang J
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2227779. PubMed ID: 37349867
[TBL] [Abstract][Full Text] [Related]
10. Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope.
Al-Omari MK; Elaarag M; Al-Zoubi RM; Al-Qudimat AR; Zarour AA; Al-Hurani EA; Fares ZE; Alkharraz LM; Shkoor M; Bani-Yaseen AD; Aboumarzouk OM; Yassin A; Al-Ansari AA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2220084. PubMed ID: 37318308
[TBL] [Abstract][Full Text] [Related]
11. U.S. Vietnamese parents' trusted sources of information and preferences for intervention messaging about HPV vaccination: A mixed methods study.
Vu M; Berg CJ; Pham NT; Tiro JA; Escoffery C; Spring B; Bednarczyk RA; Ta D; Kandula NR
PEC Innov; 2023 Dec; 3():100189. PubMed ID: 37521956
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of VEGF-mediated extracellular matrix changes through autocrine signaling.
Goggins E; Mironchik Y; Kakkad S; Jacob D; Wildes F; Bhujwalla ZM; Krishnamachary B
Cancer Biol Ther; 2023 Dec; 24(1):2184145. PubMed ID: 37389973
[TBL] [Abstract][Full Text] [Related]
13. Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis.
Wang B; Zou F; Xin G; Xiang BL; Zhao JQ; Yuan SF; Zhang XL; Zhang ZH
Pharm Biol; 2023 Dec; 61(1):868-877. PubMed ID: 37300283
[TBL] [Abstract][Full Text] [Related]
14. Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.
Adekolujo OS; Wahab A; Akanbi MO; Oyasiji T; Hrinczenko B; Alese OB
Cancer Biol Ther; 2023 Dec; 24(1):2198479. PubMed ID: 37526431
[TBL] [Abstract][Full Text] [Related]
15. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
Liu Y; Yang H
Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
[TBL] [Abstract][Full Text] [Related]
16. SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus.
Geng W; Cao M; Dong K; An J; Gao H
Cancer Biol Ther; 2023 Dec; 24(1):2206362. PubMed ID: 37170083
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor growth assessment using GFP fluorescence and DiI labeling in a zebrafish xenograft model.
Dryer Y; Berghausen J; Creswell K; Glasgow E; Brelidze TI
Cancer Biol Ther; 2023 Dec; 24(1):2234140. PubMed ID: 37455418
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma.
Xu S; Cai J; Cheng H; Wang W
Int J Pharm X; 2023 Dec; 6():100195. PubMed ID: 37448985
[TBL] [Abstract][Full Text] [Related]
19. Health system and patient-level factors associated with multidisciplinary care and patient education among hospitalized, older cancer survivors.
Brick R; Hekman DJ; Werner NE; Rodakowski J; Cadmus-Bertram L; Fields B
PEC Innov; 2023 Dec; 3():100192. PubMed ID: 37502427
[TBL] [Abstract][Full Text] [Related]
20. KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer.
Zheng Y; Wu J; Chen H; Lin D; Chen H; Zheng J; Xia H; Huang L; Zeng C
Cancer Biol Ther; 2023 Dec; 24(1):2226353. PubMed ID: 37431852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
